Resistance training may be the most effective exercise for reducing fatigue in people with multiple sclerosis (MS), a study ...

Nearly a third of RRMS patients experiencing PIRA see their disability improve later, reducing their risk of progressing to ...

Whenever I use that phrase, I mean it in the way it’s traditionally meant. Whatever it is that you’re thanking me for isn’t complete, so wait until I’m done in case you’re not entirely thankful for ...

Oligodendrocytes may show early immune-like changes in multiple sclerosis (MS), according to findings from a mouse study.

Vueway is a lower-dose gadolinium MRI contrast agent. It diagnoses/monitors conditions like multiple sclerosis with reduced gadolinium exposure. Patients prefer this agent due to its lower gadolinium ...

People with MS have a higher risk of dying by suicide than the general population, according to a meta-analysis of published ...

Simultaneously measuring levels of two blood proteins may help monitor both disease activity and disability progression in ...

A Phase 2 clinical trial testing PIPE-307, an MS experimental therapy designed to promote myelin repair, failed to meet its ...

A clinical trial testing an experimental vaccine for the Epstein-Barr virus (EBV) in people with MS is now recruiting ...

Tyruko, the first biosimilar of Tysabri, is now available in the U.S., providing a lower-cost treatment option for adults ...